Instituto Nacional de Câncer - INCA

Rio de Janeiro, Rio de Jan 20230-130

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Mantle-Cell

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling